On May 5, the American Antitrust Institute sent a letter to the U.S. Department of Justice Antitrust Division outlining concerns that the proposed acquisition of independent digital healthcare technology rival, Change Healthcare, by UnitedHealth Group (UHG) is likely to harm competition and consumers. Such harm could result from the effects of eliminating competition between UHG’s information and technology-enabled health services subsidiary, Optum, and Change Healthcare.
On May 18 at 11 a.m. Eastern, Capitol Forum is hosting a discussion with AAI’s Diana Moss to discuss the letter and AAI’s concerns that a larger and more powerful Optum could enhance UHG’s incentives to favor its dominant health insurer, UnitedHealthcare, to the disadvantage of rivals.
Tuesday, May 18 at 11:00 a.m. Eastern
Toll-free dial-in number: 800-895-3361
For more information on the event or to receive the conference ID, or for international dial-in information, please RSVP to email@example.com.
Promoting competition that protects consumers, businesses, and society is more important than ever. Through our research, education, and advocacy programs, AAI has been active in focusing public and private competition enforcement priorities and shaping progressive competition policy. The only way for AAI to fulfill its mission is through your support.